Published in

Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2, p. 19-50, 2023

DOI: 10.9734/bpi/mono/978-81-19039-63-0/ch3

American Association for the Advancement of Science, Science Advances, 50(6), 2020

DOI: 10.1126/sciadv.abe3024

Links

Tools

Export citation

Search in Google Scholar

Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm

Journal article published in 2020 by Philip A. Mudd ORCID, Jeremy Chase Crawford ORCID, Jackson S. Turner ORCID, Aisha Souquette ORCID, Daniel Reynolds, Diane Bender ORCID, James P. Bosanquet, Nitin J. Anand, David A. Striker, R. Scott Martin, R. Scott Martin, Adrianus C. M. Boon ORCID, Stacey L. House, Kenneth E. Remy ORCID, Richard S. Hotchkiss and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

Immunologic evaluation shows that most COVID-19 patients exhibit targeted immunosuppression compared to patients with influenza.